PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, 7248, Australia.\', \'Department of Respiratory Medicine, Launceston General Hospital, Launceston, TAS, 7250, Australia.\', \'Department of Cardiothoracic Surgery, Royal Hobart Hospital, Hobart, TAS, 7000, Australia.\', \'Department of Anesthesiology, Pharmacology, and Therapeutics, University of British Columbia, Vancouver, BC, Canada.\', \'Department of Medicine, University of British Columbia Centre for Heart Lung Innovation, St. Paul\'s Hospital, Vancouver, BC, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.2147/COPD.S329783
?:hasPublicationType
?:journal
  • International journal of chronic obstructive pulmonary disease
is ?:pmid of
?:pmid
?:pmid
  • 35046647
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 (COVID-19) Adhesion Site Protein Upregulation in Small Airways, Type 2 Pneumocytes, and Alveolar Macrophages of Smokers and COPD - Possible Implications for Interstitial Fibrosis.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all